Informatics Confronts Drug-drug Interactions

Overview

Journal Trends Pharmacol Sci

Specialty Pharmacology

Date 2013 Feb 19

PMID 23414686

Citations 64

Authors

Bethany Percha

Russ B Altman

Affiliations

Soon will be listed here.

Abstract

Drug-drug interactions (DDIs) are an emerging threat to public health. Recent estimates indicate that DDIs cause nearly 74000 emergency room visits and 195000 hospitalizations each year in the USA. Current approaches to DDI discovery, which include Phase IV clinical trials and post-marketing surveillance, are insufficient for detecting many DDIs and do not alert the public to potentially dangerous DDIs before a drug enters the market. Recent work has applied state-of-the-art computational and statistical methods to the problem of DDIs. Here we review recent developments that encompass a range of informatics approaches in this domain, from the construction of databases for efficient searching of known DDIs to the prediction of novel DDIs based on data from electronic medical records, adverse event reports, scientific abstracts, and other sources. We also explore why DDIs are so difficult to detect and what the future holds for informatics-based approaches to DDI discovery.

Citing Articles

Approach to Detecting Beneficial and Detrimental Drug-Drug Interactions in Complex Pharmacotherapy.

Ogura T, Shiraishi C Cureus. 2025; 17(2):e78746.

PMID: 40070640 PMC: 11893214. DOI: 10.7759/cureus.78746.

The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes.

Nguyen J, Arian C, Tanna R, Cherel M, Layton M, White J Clin Transl Sci. 2025; 18(2):e70120.

PMID: 39943692 PMC: 11821731. DOI: 10.1111/cts.70120.

Drug-Drug interactions prediction calculations between cardiovascular drugs and antidepressants for discovering the potential co-medication risks.

Zhou T, Jin T, Wang X, Wang L PLoS One. 2025; 20(1):e0316021.

PMID: 39804836 PMC: 11730380. DOI: 10.1371/journal.pone.0316021.

The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges.

Chakraborty C, Bhattacharya M, Lee S, Wen Z, Lo Y Mol Ther Nucleic Acids. 2024; 35(3):102295.

PMID: 39257717 PMC: 11386122. DOI: 10.1016/j.omtn.2024.102295.

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning.

Wang Y, Yang Z, Yao Q Commun Med (Lond). 2024; 4(1):59.

PMID: 38548835 PMC: 10978847. DOI: 10.1038/s43856-024-00486-y.

References

Segura-Bedmar I, Martinez P, de Pablo-Sanchez C . A linguistic rule-based approach to extract drug-drug interactions from pharmacological documents. BMC Bioinformatics. 2011; 12 Suppl 2:S1. PMC: 3073181. DOI: 10.1186/1471-2105-12-S2-S1. View

Thummel K, Wilkinson G . In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol. 1998; 38:389-430. DOI: 10.1146/annurev.pharmtox.38.1.389. View

Francis L, Bonilla E, Soforo E, Neupane H, Nakhla H, Fuller C . Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clin Rheumatol. 2007; 27(1):129-31. DOI: 10.1007/s10067-007-0696-9. View

Chan A, Yap K, Koh D, Low X, Cheung Y . Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians. Pharmacoepidemiol Drug Saf. 2011; 20(9):939-47. DOI: 10.1002/pds.2167. View

Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D . SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2009; 38(Database issue):D237-43. PMC: 2808967. DOI: 10.1093/nar/gkp970. View

Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M . KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2009; 38(Database issue):D355-60. PMC: 2808910. DOI: 10.1093/nar/gkp896. View

Lowe H, Ferris T, Hernandez P, Weber S . STRIDE--An integrated standards-based translational research informatics platform. AMIA Annu Symp Proc. 2010; 2009:391-5. PMC: 2815452. View

Takarabe M, Shigemizu D, Kotera M, Goto S, Kanehisa M . Network-based analysis and characterization of adverse drug-drug interactions. J Chem Inf Model. 2011; 51(11):2977-85. DOI: 10.1021/ci200367w. View

Yap K, Kuo E, Lee J, Chui W, Chan A . An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project. Support Care Cancer. 2009; 18(7):883-91. DOI: 10.1007/s00520-009-0729-9. View

10.

Hall M, DeFrances C, Williams S, Golosinskiy A, Schwartzman A . National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report. 2010; (29):1-20, 24. View

11.

Moura C, Acurcio F, Belo N . Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2010; 12(3):266-72. DOI: 10.18433/j35c7z. View

12.

Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, Motola D . Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy. Drug Saf. 2010; 33(8):667-75. DOI: 10.2165/11534400-000000000-00000. View

13.

Hung I, Wu A, Cheng V, Tang B, To K, Yeung C . Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis. 2005; 41(3):291-300. DOI: 10.1086/431592. View

14.

Duke J, Han X, Wang Z, Subhadarshini A, Karnik S, Li X . Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol. 2012; 8(8):e1002614. PMC: 3415435. DOI: 10.1371/journal.pcbi.1002614. View

15.

Tatonetti N, Ye P, Daneshjou R, Altman R . Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012; 4(125):125ra31. PMC: 3382018. DOI: 10.1126/scitranslmed.3003377. View

16.

Zhang L, Zhang Y, Zhao P, Huang S . Predicting drug-drug interactions: an FDA perspective. AAPS J. 2009; 11(2):300-6. PMC: 2691466. DOI: 10.1208/s12248-009-9106-3. View

17.

Klein T, Chang J, Cho M, Easton K, Fergerson R, Hewett M . Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J. 2002; 1(3):167-70. DOI: 10.1038/sj.tpj.6500035. View

18.

Becker M, Kallewaard M, Caspers P, Visser L, Leufkens H, Stricker B . Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2006; 16(6):641-51. DOI: 10.1002/pds.1351. View

19.

Rogers R, Prpic R . Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy. Med J Aust. 1998; 169(8):425-7. View

20.

Percha B, Garten Y, Altman R . Discovery and explanation of drug-drug interactions via text mining. Pac Symp Biocomput. 2011; :410-21. PMC: 3345566. View